Medicine & Health News

TAU researchers double adult stem cells for bone marrow regeneration

An international research team led by scientists from Tel Aviv University (TAU) and Sheba Medical Center has unveiled an innovative method for activating adult stem cells from human bone marrow, enabling their expansion outside the body for use in bone marrow regeneration and the construction of a new blood and immune system. The findings, published… Read More

TAU researchers use CRISPR to cut a gene from head and neck cancers

Researchers from Tel Aviv University (TAU) used the genetic editing tool CRISPR to cut a single gene from cancer cells of head and neck tumors, which successfully eliminated 50% of the tumors in model animals. This groundbreaking study was led by Dr. Razan Masarwy, MD, PhD, from the lab of Professor Dan Peer. Professor Peer… Read More

TAU researchers successfully deliver mRNA-based drugs directly to the intestine

Researchers at Tel Aviv University (TAU) have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of the small and large intestines, bypassing the liver upon systemic administration. They characterize this as a major breakthrough in drug delivery. The groundbreaking study was led by post-doctoral fellow Dr. Riccardo Rampado together with Professor… Read More

TAU study discovers how foreign DNA can evade and neutralize bacterial defense systems

A new study from Tel Aviv University (TAU) researchers reveals how bacterial defense mechanisms can be neutralized, enabling the efficient transfer of genetic material between bacteria. The researchers believe this discovery could pave the way for developing tools to address the antibiotic resistance crisis and promote more effective genetic manipulation methods for medical, industrial, and… Read More

New nasal COVID-19 vaccine developed by TAU

Professor Ronit Satchi-Fainaro‘s lab at the Faculty of Medical and Health Sciences at Tel Aviv University (TAU) collaborated with Professor Helena Florindo’s lab at the University of Lisbon to produce a novel nano-vaccine for COVID-19. The nano-vaccine, a 200-nanometer particle, trains the immune system against all common COVID-19 variants just as effectively as existing vaccines…. Read More

TAU researchers identify key role of NMDA receptors in brain function

Researchers at Tel Aviv University (TAU) have determined that the NMDA receptor (NMDAR) in the brain, long studied primarily for its role in learning and memory, also plays a crucial role in stabilizing brain activity. By setting the “baseline” level for activity in neural networks, the NMDAR helps maintain stable brain function amidst continuous environmental… Read More